Wealthfront Advisers LLC Boosts Holdings in Cardinal Health, Inc. $CAH

Wealthfront Advisers LLC raised its holdings in Cardinal Health, Inc. (NYSE:CAH) by 2.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 55,245 shares of the company’s stock after purchasing an additional 1,226 shares during the quarter. Wealthfront Advisers LLC’s holdings in Cardinal Health were worth $9,281,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Principal Financial Group Inc. boosted its holdings in Cardinal Health by 5.3% in the first quarter. Principal Financial Group Inc. now owns 315,817 shares of the company’s stock valued at $43,510,000 after purchasing an additional 15,956 shares during the last quarter. Golden State Wealth Management LLC grew its position in shares of Cardinal Health by 569.5% during the 1st quarter. Golden State Wealth Management LLC now owns 395 shares of the company’s stock valued at $54,000 after acquiring an additional 336 shares during the period. North Capital Inc. purchased a new position in shares of Cardinal Health in the 1st quarter valued at about $83,000. KLP Kapitalforvaltning AS increased its stake in shares of Cardinal Health by 4.0% in the 2nd quarter. KLP Kapitalforvaltning AS now owns 114,198 shares of the company’s stock valued at $19,185,000 after purchasing an additional 4,400 shares in the last quarter. Finally, Czech National Bank raised its holdings in Cardinal Health by 5.1% in the 2nd quarter. Czech National Bank now owns 58,341 shares of the company’s stock worth $9,801,000 after purchasing an additional 2,857 shares during the period. 87.17% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. Leerink Partners increased their price target on Cardinal Health from $186.00 to $187.00 and gave the stock an “outperform” rating in a research report on Monday, October 6th. Argus set a $189.00 price target on Cardinal Health in a research report on Friday, August 22nd. Morgan Stanley reiterated an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Jefferies Financial Group set a $150.00 price target on Cardinal Health in a research report on Tuesday, August 12th. Finally, Wall Street Zen downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 2nd. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $166.00.

Cardinal Health Trading Up 1.2%

CAH stock opened at $163.76 on Tuesday. The company has a market cap of $38.91 billion, a price-to-earnings ratio of 25.39, a PEG ratio of 1.37 and a beta of 0.71. Cardinal Health, Inc. has a 12 month low of $106.98 and a 12 month high of $168.44. The firm has a 50-day moving average of $153.04 and a two-hundred day moving average of $153.26.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating analysts’ consensus estimates of $2.03 by $0.05. The company had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. Cardinal Health’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, equities analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were issued a dividend of $0.5107 per share. The ex-dividend date was Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.2%. Cardinal Health’s dividend payout ratio (DPR) is currently 31.63%.

Insider Buying and Selling at Cardinal Health

In other news, insider Jessica L. Mayer sold 38,078 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the completion of the sale, the insider owned 48,457 shares in the company, valued at $7,211,370.74. This trade represents a 44.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Michelle D. Greene sold 13,500 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the sale, the insider owned 14,976 shares of the company’s stock, valued at $2,228,728.32. This represents a 47.41% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 271,676 shares of company stock worth $40,489,525. Insiders own 0.12% of the company’s stock.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.